Therapix Biosciences and Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing and Royalty Agreement
January 12, 2015 16:30 ET
|
Therapix Biosciences Ltd.
TEL AVIV, Israel, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Therapix Bio (TASE:THXBY) (OTCQB:THXBY) today announced that it has entered into a binding Term Sheet outlining a licensing and royalty agreement...
Therapix Biosciences Enters Strategic Collaboration for Development and Commercialization of Oral Anti-CD3 Antibody in China
December 23, 2014 09:15 ET
|
Therapix Biosciences Ltd.
TEL AVIV, Israel, Dec. 23, 2014 (GLOBE NEWSWIRE) -- Therapix Bio (TASE:TRPX) (OTCQB:THXBY) today announced that its subsidiary, OrImmune Bio Ltd., has entered into a non-binding memorandum of...
Therapix Biosciences Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd.
October 21, 2014 08:30 ET
|
Therapix Biosciences Ltd.
TEL AVIV, Israel, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Therapix Bio (TASE:TRPX) (OTCQB:THXBY) announces that it recently entered into a Term Sheet for the acquisition of Dekel Pharmaceuticals Ltd., a...
Therapix Biosciences Names Jan Turek CEO
October 20, 2014 08:30 ET
|
Therapix Biosciences Ltd.
TEL AVIV, Israel, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Therapix Bio (TASE:TRPX) (OTCQB:THXBY) today announced that Jan Turek has been named Chief Executive Officer, effective as of September 22nd, 2014....
Therapix Biosciences ADRs Begin Trading on the OTCQB(R)
October 07, 2014 09:00 ET
|
Therapix Biosciences Ltd.
TEL AVIV, Israel, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Therapix Bio (TASE:TRPX) (OTC:THXBY) today announced that its American Depository Receipts (ADRs) have been registered and approved for trading on...